Assessment of Energy Metabolism in Metabolic Myopathies
NCT07268287 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3
Last updated 2025-12-05
Summary
Patients with metabolic myopathies suffer from exercise intolerance due to impaired ability to produce energy and secondary de-conditioning. There is a lack of methods enabling a non-invasive assessment of muscle energy production and studies regarding the benefits of therapeutic interventions are lacking as well. In this pilot study, the main aim is to assess the benefit of an intervention: a regular at home physiotherapy program for metabolic myopathies by measuring different outcomes pre and post therapeutic intervention using minimally invasive tests. The secondary aim of this study: investigators plan to describe the results of established non-invasive stable isotope tracer tests, namely, "glucose breath test" and "doubly labelled water \& urine test" in patients pre and post 12 weeks at-home physiotherapy exercise program. The results of this study will be used for a larger scale study to assess energy metabolism in patients in patients with metabolic myopathies using non-invasive tests like breath and urine tests.
Conditions
- Metabolic Myopathies
Interventions
- OTHER
-
12-week Physiotherapy Intervention
A 12 week at-home physiotherapy exercises program performed at least 5 times per week, under virtual supervision 3 times per week by a kinesiologist, contains the same type of exercises that are normally prescribed to this population on a clinical basis. All patients will perform the same program to reduce inter-variability.
- DIETARY_SUPPLEMENT
-
13C-Glucose Breath Test
Experiment piece 1: Oral glucose isotope is administered to fasted participants on pre and post-intervention study days. Breath is collected over a 4-hour period following ingestion. Other Names: • D-glucose (Thermo Scientific™ NERL™ Trutol™)
- DIETARY_SUPPLEMENT
-
Doubly labelled water & urine test
Experiment piece 2: 1 study day pre and post-intervention fasted participants ingest a single oral dose of doubly labelled water (2H218O) isotope. 4 urine samples are collected over a 4 hour period following isotope administration, and once a day over 14 days. DLW is a safe and minimally invasive technique, considered the gold standard for precise measurement energy expenditure in humans. It involves enriching the body water with heavy hydrogen and oxygen (2H218O). The method is based on the principle that the 2H2 derived from body water is eliminated only as water (2H2O), while 18O is eliminated as both water (H2 18O) and carbon dioxide (C18O2).
- DIAGNOSTIC_TEST
-
Clinical Assessments - Exercise Test
Experiment piece 3: Using a well-established clinical method VO2 max, once pre and post-intervention to assess for body composition (oxygen consumption during exercise).
- DIAGNOSTIC_TEST
-
Clinical Assessment - Muscle Content
Experiment piece 3: Using a well-established clinical method, DXA, once pre and post-intervention to assess for body muscle content (lean muscle mass)
- DIAGNOSTIC_TEST
-
Clinical Assessment - Quality of Life
Experiment piece 3: Using a well-established clinical survey, PedsQL, once pre and post-intervention to assess for participants perception of quality of life.
Sponsors & Collaborators
-
University of British Columbia
lead OTHER
Principal Investigators
-
Rajavel Elango, PhD · University of British Columbia
-
Catherine Brunel, MD, FRCPS, FCCMG · Provincial Health Services Authority British Columbia
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 10 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-06-26
- Primary Completion
- 2024-05-24
- Completion
- 2025-10-08
Countries
- Canada
Study Locations
More Related Trials
-
Magnetic Resonance Imaging (MRI) Muscle Phenotyping in Mitochondrial Disease
NCT02154711 ·Status: COMPLETED
-
Safety, Tolerability, and Efficacy of MTP-131 for the Treatment of Mitochondrial Myopathy
NCT02367014 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase 2 Study to Evaluate the Impact of MTP-131 (Bendavia™) on Skeletal Muscle Function in Elderly
NCT02245620 ·Status: COMPLETED ·Phase: PHASE2
-
New Therapeutic Strategy in ALS Based on Metabolic Status and Associated Metabolic Pathways.
NCT03984708 ·Status: COMPLETED ·Phase: NA
-
A Clinical Study to Assess the Effects of SRT2104 Upon Immobilization-Induced Skeletal Muscle Atrophy in Healthy Human Volunteers
NCT01039909 ·Status: WITHDRAWN ·Phase: PHASE1
-
Mechanisms and Treatment of Exercise Intolerance and Persistent Fatigue in Spinal Muscular Atrophy
NCT05518773 ·Status: COMPLETED
-
Prognostic Value of a Diaphragmatic Endurance Test in Patients With Amyotrophic Lateral Sclerosis
NCT02528071 ·Status: TERMINATED
-
The Safety, Efficacy and Tolerability of Remote Ischemic Preconditioning as a Therapy to DMD
NCT02614820 ·Status: UNKNOWN ·Phase: NA
-
Muscular Biomarkers in Amyotrophic Lateral Sclerosis
NCT02670226 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate a Skeletal-muscle Microbiopsy Technique With Dynamic Proteomic Measurement in Healthy Male Volunteers
NCT01962454 ·Status: COMPLETED ·Phase: PHASE1
-
Mitochondrial Video Assessment Source Material Study
NCT06180421 ·Status: COMPLETED
-
Non-invasive Imaging of Muscle Structure in Duchenne Muscular Dystrophy Using Multispectral Optoacoustic Tomography
NCT03490214 ·Status: COMPLETED ·Phase: NA
-
Characterization of New Phenotypes of Patients With Spinal Muscular Atrophy Treated With SMN Restoring Therapy
NCT06321965 ·Status: RECRUITING ·Phase: NA
-
Exploring the Physiologic, Pharmacodynamic, and Clinical Responses of Skeletal Muscle in Patients With Spinal Muscular Atrophy Treated With SMN-Directed Therapies
NCT06532474 ·Status: RECRUITING
-
Nutritional Assessment in Mitochondrial Cytopathy
NCT02375438 ·Status: COMPLETED
-
Carbon-13 Magnetic Resonance Spectroscopy in Glycogen Storage Diseases
NCT04929002 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical Outcome Measures in Myotonic Dystrophy Type 2
NCT03603171 ·Status: COMPLETED
-
Multispectral Optoacoustic Tomography for Advanced Imaging of Centronuclear Myopathy
NCT07021820 ·Status: RECRUITING
-
Electrical Impedance Myography as an Outcome Measure in Amyotrophic Lateral Sclerosis Clinical Trials
NCT00620698 ·Status: COMPLETED
-
Clinical, Biological and NMR Outcome Measures Study for Hereditary Inclusion Body Myopathy Due to Mutation of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine Kinase Gene (GNE)
NCT02196909 ·Status: COMPLETED ·Phase: NA
-
Multicenter Observational Study of Myotonic Dystrophy Type 1
NCT02308657 ·Status: COMPLETED
-
Study of Muscle Wasting and Altered Metabolism in Patients With Myotonic Dystrophy
NCT00004769 ·Status: COMPLETED
-
The Natural History and Muscle Fatigability of Patients With Congenital Myopathies.
NCT06157268 ·Status: RECRUITING
-
Biomarker Development for Muscular Dystrophies
NCT05019625 ·Status: RECRUITING
-
A Study to Assess the Safety and Effectiveness of FLX-787 in Subjects With Charcot-Marie-Tooth Disease Experiencing Muscle Cramps.
NCT03254199 ·Status: TERMINATED ·Phase: PHASE2